A United States jury has found glyphosate-based Roundup weedkiller to be a “considerable factor” in causing a man’s malignancy. It is the second such court ruling against the herbicide in under a year.
US District Court takes the unanimous decision in California which discovered that Roundup developed non-Hodgkin’s lymphoma in 70-year-old Edwin Hardeman. He utilized it for about 30 years to control weeds on his property.
Be that is may, the case presently moves to a second stage, which will decide damages and liabilities.
Bayer, the proprietor of Monsanto, which makes Roundup weedkiller, said in an explanation the jury’s initial decision baffled him.
“We continue to believe firmly that the science confirms glyphosate-based herbicides do not cause cancer,” the company said.
“We are confident the evidence in phase two will show that Monsanto’s conduct has been appropriate and the company should not be liable for Mr. Hardeman’s cancer.”
Mr. Hardeman’s legal counselors said they would indicate proof of Monsanto’s “bad conduct” in the following phase of the trial.
Furthermore, Monsanto has unequivocally shielded Roundup with a decades-long advertising effort.
A year ago, another jury found that Roundup had caused the cancer growth of a school janitor in California.
He was granted $US289 million, but that was later decreased to $US78 million.
Bayer is engaging the case.
The present case is a “bellwether” for several other pending lawsuits in the US.
Altogether, Bayer is confronting in excess of 11,000 similar cases in the US.